Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/335-a-phase-3-multi-site-randomized-double-blind-placebo-controlled-parallel-group-study-of-the-efficacy-and-safety-of-2-oral-doses-of-cp-690550-and-1-subcutaneous-dose-of-etanercept-in-subjects-with-moderate-to-severe-chronic-plaque-psoriasis/publications